Bildkälla: Stockfoto

Lipigon Q1 2024: Phase II Underway - Redeye

Redeye comments on Lipigon's Q1 report 2024. Since our last update, patient recruitment to the phase II study of Lipisense has begun.

Redeye comments on Lipigon's Q1 report 2024. Since our last update, patient recruitment to the phase II study of Lipisense has begun.
Börsvärldens nyhetsbrev
ANNONSER